© Valitor, Inc 2020

  • LinkedIn - White Circle
Search
  • mmahomed2

Phase I SBIR grant from the National Institute of Arthritis and Musculoskeletal and Skin Diseases

Valitor, Inc. has been awarded a Phase I SBIR grant from the National Institute of Arthritis and Musculoskeletal and Skin Diseases. This project is designed to evaluate proof-of-concept for our multivalent protein conjugation technology to accelerate wound closure for patients who exhibit impaired wound healing associated with diabetes.

3 views